New CDC studies reveal that early treatment of HIV patients significantly improves outcomes and recommend viral load testing to identify treatment failures. The findings also address challenges in ART enrollment rates, providing insights for better patient retention strategies.
New collaborative studies being presented by the Centers for Disease Control and Prevention (CDC) at the XIX International AIDS Conference confirm early treatment of HIV patients results in better outcomes, suggest use of viral load testing to detect treatment failure, and highlight factors associated with low rate of ART enrollment.
Original title: “New CDC studies point to better practices in timing, testing, and retention of patients in HIV anti-retroviral drug treatment (ART) in Africa”